Boston Financial Mangement LLC Has $31.05 Million Stock Position in Waters Co. (NYSE:WAT)

Boston Financial Mangement LLC lessened its stake in Waters Co. (NYSE:WAT) by 0.5% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 83,707 shares of the medical instruments supplier’s stock after selling 451 shares during the quarter. Boston Financial Mangement LLC owned 0.14% of Waters worth $31,054,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in WAT. Principal Financial Group Inc. lifted its stake in Waters by 70.7% in the 3rd quarter. Principal Financial Group Inc. now owns 656,019 shares of the medical instruments supplier’s stock valued at $236,095,000 after acquiring an additional 271,804 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its position in shares of Waters by 34.4% in the third quarter. Robeco Institutional Asset Management B.V. now owns 393,890 shares of the medical instruments supplier’s stock worth $141,757,000 after purchasing an additional 100,811 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Waters by 37.2% during the third quarter. JPMorgan Chase & Co. now owns 305,661 shares of the medical instruments supplier’s stock worth $110,005,000 after purchasing an additional 82,865 shares during the last quarter. Applied Finance Capital Management LLC grew its position in Waters by 3,627.0% in the third quarter. Applied Finance Capital Management LLC now owns 68,987 shares of the medical instruments supplier’s stock valued at $24,828,000 after purchasing an additional 67,136 shares in the last quarter. Finally, Smith Group Asset Management LLC acquired a new stake in Waters in the 4th quarter valued at $22,188,000. Institutional investors own 94.01% of the company’s stock.

Waters Stock Up 0.3 %

WAT stock opened at $377.30 on Thursday. The business’s fifty day moving average price is $388.97 and its two-hundred day moving average price is $365.18. The stock has a market capitalization of $22.40 billion, a price-to-earnings ratio of 35.23, a PEG ratio of 3.74 and a beta of 1.01. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $423.56. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65.

Waters (NYSE:WAT) last issued its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. On average, equities analysts anticipate that Waters Co. will post 12.86 earnings per share for the current year.

Analyst Upgrades and Downgrades

WAT has been the subject of several analyst reports. Stifel Nicolaus raised their price objective on Waters from $332.00 to $360.00 and gave the company a “hold” rating in a report on Monday, November 4th. Deutsche Bank Aktiengesellschaft upped their price objective on Waters from $310.00 to $325.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. JPMorgan Chase & Co. boosted their target price on shares of Waters from $340.00 to $380.00 and gave the stock a “neutral” rating in a report on Monday, November 4th. TD Cowen increased their price target on shares of Waters from $363.00 to $410.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Finally, StockNews.com raised shares of Waters from a “hold” rating to a “buy” rating in a report on Monday. Ten analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $390.40.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.